Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amicus Therapeutics Inc (NASDAQ:FOLD)

7.36
Delayed Data
As of 3:59pm ET
 -0.14 / -1.87%
Today’s Change
4.41
Today|||52-Week Range
9.83
+48.09%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues363.0K1.2M0.005.0M
 
 
 
 
Cost of Goods Sold----0.00833.0K
 
 
Depreciation And Amortization1.7M1.5M1.8M3.2M
 
 
 
 
 
 
Operating ExpensesGross Income-----1.8M883.0K
 
 
 
General Expenses60.3M68.3M121.1M169.4M
 
 
 
 
 
Research And Development41.9M47.6M76.9M98.3M
 
 
 
 
 
Total Operating Expenses62.1M69.9M122.9M173.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-61.7M-68.7M-122.9M-168.6M
 
 
 
 
 
Extraordinary Credit908.0K63.0K0.000.00
 
 
 
Extraordinary Charge-2.5M-100.0K-8.4M-26.9M
 
 
 
 
 
Interest Expense On Debt46.0K1.5M1.6M5.4M
 
 
 
 
 
Other Expenses0.00-77.0K-80.0K-4.5M
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-63.1M-70.0M-132.1M-203.8M
 
 
 
 
 
Income Taxes-3.5M-1.1M0.00-3.7M
 
 
 
 
Net Income-59.6M-68.9M-132.1M-200.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS51.3M74.4M109.9M134.4M
 
 
 
 
 
Shares To Calculate EPS Diluted51.3M74.4M109.9M134.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.16-$0.93-$1.20-$1.49
 
 
 
 
 
EPS Diluted-$1.16-$0.93-$1.20-$1.49